Could bioengineered exosome-mimetic nanovesicles be an efficient strategy for the delivery of chemotherapeutics?

Nanomedicine

Volumn 9, Issue 2, 2014, Pages 177-180

  Jang, Su Chul ^a   Gho, Yong Song ^a  

^a Pohang University of Science and Technology (POSTECH)   (South Korea)

Author keywords

Drug delivery system; Exosome mimetics; Extracellular vesicle; Nanomedicine; Nanovesicle

Indexed keywords

ANTINEOPLASTIC AGENT; CARBOPLATIN; DOXORUBICIN; FLUOROURACIL; GEMCITABINE; LIPOSOME; NANOCARRIER; PROTEIN;

BIOENGINEERING; CELL SURFACE; CELL VACUOLE; CROSS LINKING; DRUG DELIVERY SYSTEM; DRUG PURITY; EUKARYOTIC CELL; EXOSOME; EXOSOME MIMETIC NANOVESICLE; HUMAN; IMMUNOGENICITY; INTERNALIZATION; MESENCHYMAL STEM CELL; MULTIDRUG RESISTANCE; NANOMEDICINE; NANOTECHNOLOGY; NEOPLASM; NONHUMAN; NUCLEAR REPROGRAMMING; PRIORITY JOURNAL; REVIEW; TISSUE REGENERATION;

DRUG DELIVERY SYSTEMS; EXOSOMES; HUMANS; MOLECULAR MIMICRY; NANOSTRUCTURES;

EID: 84896711018     PISSN: 17435889     EISSN: 17486963     Source Type: Journal    
DOI: 10.2217/nnm.13.206     Document Type: Review

References (18)

1. Peer D, Karp JM, Hong S, Farokhzad OC, Margalit R, Langer R. Nanocarriers as an emerging platform for cancer therapy. Nat. Nanotechnol. 2(12), 751-760 (2007).
2. Puri A, Kramer-Marek G, Campbell-Massa R et al. HER2-specific affibody-conjugated thermosensitive liposomes (affisomes) for improved delivery of anticancer agents. J. Liposome Res. 18(4), 293-307 (2008).
3. Davis ME, Chen ZG, Shin DM. Nan oparticle therapeutics: An emerging treatment modality for cancer. Nat. Rev. Drug Discov. 7(9), 771-782 (2008).
4. Ferrari M. Nanogeometry: Beyond drug delivery. Nat. Nanotechnol. 3(3), 131-132 (2008).
5. Roth JC, Curiel DT, Pereboeva L. Cell vehicle targeting strategies. Gene Ther. 15(10), 716-729 (2008).
6. Doherty GJ, McMahon HT. Mechanisms of endocytosis. Annu. Rev. Biochem. 78, 857-902 (2009).
7. Simons M, Raposo G. Exosomes-vesicular carriers for intercellular communication. Curr. Opin. Cell Biol. 21(4), 575-581 (2009).
8. Lee EY, Choi DY, Kim DK et al. Gram-positive bacteria produce membrane vesicles: Proteomics-based characterization of Staphylococcus aureus-derived membra ne vesicles. Proteomics 9(24), 5425-5436 (2009).
9. Choi DS, Kim DK, Kim YK, Gho YS. Proteomics, transcriptomics and lipidomics of exosomes and ectosomes. Proteomics 13(10-11), 1554-1571 (2013).
10. Sun D, Zhuang X, Xiang X et al. A novel nanoparticle drug delivery system: The anti-inflammatory activity of curcumin is enhanced when encapsulated in exosomes. Mol. Ther. 18(9), 1606-1614 (2010).
11. Alvarez-Erviti L, Seow Y, Yin H, Betts C, Lakhal S, Wood MJ. Delivery of SIRNA to the mouse brain by systemic injection of targeted exosomes. Nat. Biotechnol. 29(4), 341-345 (2011).
12. Sun D, Zhuang X, Zhang Set al. Exosomes are endogenous nanoparticles that can deliver biological information between cells. Adv. Drug Deliv. Rev. 65(3), 342-347 (2013).
13. Ohno S, Takanashi M, Sudo K et al. Systemically injected exosomes targeted to EGFR deliver antitumor microRNA to breast cancer cells. Mol. Ther. 21(1), 185-191 (2013).
14. Jang SC, Kim OY, Yoon CM et al. Bioinspired exosome-mimetic nanovesicles for targeted delivery of chemotherapeutics to malignant tumors. ACS Nano 7(9), 7698-7710 (2013).
15. Mauriz JL, Gonzalez-Gallego J. Antiangiogenic drugs: Current knowledge and new approaches to cancer therapy. J. Pharm. Sci. 97(10), 4129-4154 (2008).
16. Camussi G, Deregibus MC, Bru no S, Grange C, Fonsato V, Tetta C. Exosome/microvesicle-mediated epigenetic reprogramming of cells. Am. J. Cancer Res. 1(1), 98-110 (2011).
17. Lai RC, Arslan F, Lee MM et al. Exosome secreted by MSC reduces myocardial ischemia/reperfusion injury. Stem Cell Res. 4(3), 214-222 (2010).
18. Nishiyama N. Nanomedicine: Nanocarriers shape up for long life. Nat. Nanotechnol. 2(4), 203-204 (2007).